Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Bajaj Finserv Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 27-Dec-24
Corpus(Cr.) 405.00 Latest NAV 11.361 As on 29-10-2026
Equity(%) 95.56 52 Week High 12.078
Debt(%) 4.44 52 Week Low 8.965
Others(%) 0.00 Exit Load 1% for redemption within 3 months
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sorbh Gupta
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 37.18%
Top 10 Holdings 59.23%
Top 25 Holdings 90.76%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 73.73
Healthcare 15.62
Cash 3.13
Food Beverage & Tobacco 2.2
Consumer Durables 1.88
Debt MF 1.31
Chemicals 1.17
Miscellaneous 0.75
Fertilisers 0.21
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.99
PE Ratio 48.10
 
Top 25 Holdings
Holdings Net Asset(%)
Divis Laboratories Ltd. 9.75
Sun Pharmaceutical Industries Ltd. 8.96
PIRAMAL PHARMA LIMITED 6.36
RUBICON RESEARCH LIMITED 6.08
Aurobindo Pharma Ltd. 6.03
Apollo Hospitals Enterprises Ltd. 5.51
Torrent Pharmaceuticals Ltd. 4.78
Emcure Pharmaceuticals Limited 4.03
Laurus Labs Limited 3.91
Neuland Laboratories Limited. 3.82
Max Healthcare Institute Limited 2.99
Alkem Laboratories Limited 2.96
Zydus Lifesciences Limited 2.57
Ipca Laboratories Ltd. 2.40
Clearing Corporation of India Ltd 2.32
Fortis Healthcare Ltd 2.28
Zydus Wellness Limited 2.20
Vijaya Diagnostic Centre Limited 2.19
SENORES PHARMACEUTICALS LIMITED 2.08
Shaily Engineering Plastics Ltd. 1.88
Dr. Lal Pathlabs Limited 1.73
GlaxoSmithkline Pharmaceuticals Ltd. 1.63
Glenmark Pharmaceuticals ltd 1.60
Dr. Reddys Laboratories Ltd. 1.37
Cipla Ltd. 1.33

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-2.48% -0.36% 15.34% 15.16%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [BSE Healthcare]
-3.04% -2.20% 11.33% 10.26%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
0.00% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
7.24% 22.06% 14.69% 11.73%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Bajaj Finserv Healthcare Fund Reg (G) 0.00% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Bajaj Finserv Healthcare Fund Reg (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection